SKB BIO(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06990 SKB BIO

Not Yet Opened 09-02 16:08:07

493.000

+3.200

+0.65%

High499.600	Low480.200	Vol463.51K
Open480.200	D1 Closing489.800	Amplitude3.96%
Mkt Cap117.83B	Tradable Cap87.26B	Total Shares239.00M
T/O228.06M	T/O Rate0.26%	Tradable Shares177.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":493,"timestamp":1788336487009,"preClose":489.8,"halted":0,"volume":463511,"delay":0,"changeRate":0.006533278889342566,"floatShares":177000000,"shares":239000000,"eps":-1.9340943679422837,"marketStatus":"Not Yet Opened","change":3.2,"latestTime":"09-02 16:08:07","open":480.2,"high":499.6,"low":480.2,"amount":228056110,"amplitude":0.039608,"askPrice":493,"askSize":2300,"bidPrice":492.6,"bidSize":400,"shortable":3,"etf":0,"ttmEps":0.7566995523839398,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":489.8,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"volumeRatio":0.607013,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06990","defaultTab":"news","newsList":[{"id":"1182575724","title":"Movement Alert｜SKB BIO Falls 3.4% in Regular Trading, Biotechnology Sector Under Broad Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=1182575724","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182575724?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:39","pubTimestamp":1788140397,"startTime":"0","endTime":"0","summary":"On August 31, SKB BIO fell 3.4% in regular trading, trading at 503.5 HKD/share, with turnover of approximately 13.62 million HKD. The decline came amid broad-based weakness across the biotechnology...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SKB BIO Drops as Southbound Capital Sells for 17 of 20 Days","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125806134","title":"Movement Alert｜SKB BIO Falls 3.16% in Regular Trading, Trading at HK$519.5","url":"https://stock-news.laohu8.com/highlight/detail?id=1125806134","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125806134?lang=en_us&edition=fundamental","pubTime":"2026-08-24 10:44","pubTimestamp":1787539499,"startTime":"0","endTime":"0","summary":"On August 24, SKB BIO fell 3.16% in regular trading, trading at HK$519.5/share, with turnover of HK$75.84 million.Within the Biotechnology sector where SKB BIO belongs, the overall sector performance...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661285219","title":"Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) After Profitability And Oncology Progress Looks Undervalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2661285219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661285219?lang=en_us&edition=fundamental","pubTime":"2026-08-22 20:26","pubTimestamp":1787401593,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has drawn fresh attention after reporting a shift to profitability in its half year 2026 results, along with a series of product milestones across its oncology portfolio.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThe recent run of clinical milestones, regulatory decisions and the shift to profitability appears to have supported sentiment in Sichuan Kelun-Biotech Biopharmaceutical, with the stock delivering a 13.45%...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotech-biopharmaceutical-sehk6990-after-profi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotech-biopharmaceutical-sehk6990-after-profi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","LU2065732104.USD","BK4585","BK4588","BK1161","LU0196878994.USD","PRGS","XBI","BK4097","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198772075","title":"Historic Breakthrough in mRNA Cancer Vaccines: E Fund Biotech ETF (03186) Taps Innovation Opportunities Across Hong Kong and US Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1198772075","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198772075?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:50","pubTimestamp":1787215857,"startTime":"0","endTime":"0","summary":"On August 19, Moderna and Merck announced that their personalized mRNA cancer vaccine combined with Keytruda met the interim analysis goals in a Phase 3 trial for melanoma. This marks the world's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","06990","LU2488822045.USD","09688","BK1587","LU0196878994.USD","159929","159646","02162","BK1583","BK1161","03186","BK1588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192398601","title":"SKB BIO Receives Price Target Increase to HK$642 with Buy Rating Maintained by BOCOM International","url":"https://stock-news.laohu8.com/highlight/detail?id=1192398601","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192398601?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:10","pubTimestamp":1787206232,"startTime":"0","endTime":"0","summary":"BOCOM International has released a research report raising the target price for SKB BIO (06990) to HK$642, while reiterating its \"Buy\" rating on the stock.The firm notes that the company's first-half...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","EWH","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158850916","title":"Movement Alert｜SKB BIO Rises 4.11% in Regular Trading, Multiple Investment Banks Raise Target Prices Boosting Market Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1158850916","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158850916?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:42","pubTimestamp":1787190169,"startTime":"0","endTime":"0","summary":"On August 20, SKB BIO rose 4.11% in regular trading, trading at 554.5 HKD/share with turnover of HKD 86.47 million, rebounding sharply from the prior session's pullback. On August 19, multiple...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SKB BIO Rises as Multiple Investment Banks Raise Target Prices Boosting Market Confidence","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479671","title":"China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479671","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479671?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:17","pubTimestamp":1787181459,"startTime":"0","endTime":"0","summary":"China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-upOverviewChina oncology drug developer's H1 revenue rose 29% yr/yr on higher product salesNet loss widened as operating expenses and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G15G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","BK0239","IE00BZ08YT58.USD","BK1515","BK1574","LU1064131003.USD","002422","01177","LU1979443071.USD","BK1589","BK1191","LU1064130708.USD","BK0060","LU1934453819.USD","IE00BZ08YR35.GBP","LU0196878994.USD","HK0000165453.HKD","BK1521","LU2148510915.USD","06855","BK1161","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479273","title":"Earnings Update: Here's Why Analysts Just Lifted Their Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) Price Target To HK$612","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479273","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479273?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:27","pubTimestamp":1787178460,"startTime":"0","endTime":"0","summary":"Last week saw the newest interim earnings release from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ( HKG:6990...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/earnings-update-heres-why-analysts-just-lifted-their-sichuan","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/earnings-update-heres-why-analysts-just-lifted-their-sichuan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445122","title":"Sino Biopharmaceutical H1 Revenue up 10.6% on Innovative Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445122","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445122?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:42","pubTimestamp":1787128954,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical H1 revenue up 10.6% on innovative drug salesOverviewChina pharma group's H1 2026 revenue rose 10.6% yr/yr, driven by innovative drug salesNet profit attributable to owners grew ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G09L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK1521","SG9999001176.SGD","LU0757432116.USD","00867","IE00BKPKM643.USD","LU1078025761.USD","LU1983299246.USD","LU0553294199.USD","SG9999015952.SGD","LU0171293334.USD","IE00BVYPNP33.GBP","LU0047473722.SGD","LU2293690082.USD","LU0964806797.USD","SG9999001176.USD","BK1191","LU0266013472.USD","AZN.UK","IE00BFTCPJ56.SGD","LU0545039389.USD","LU1481600234.SGD","BK5011","LU1051770623.HKD","LU2279689827.SGD","LU0211326755.USD","LU0997586432.USD","01177","06990","LU0784384876.USD","LU0047473722.EUR","LU0784385170.HKD","002422","LU2293690249.USD","LU0122379950.USD","LU1989772840.SGD","LU1496350502.SGD","LU0969580561.USD","LU1267930490.SGD","IE0034235188.USD","LU2433249047.HKD","LU0887340254.USD","LU0920840948.USD","LU0310799852.SGD","03165","LU0052756011.USD","SGXZ57979304.SGD","LU2108987350.USD","LU2133065610.SGD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155030001","title":"BofA Securities Raises SKB BIO Price Target to HK$644.4, Projects Full-Year Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=1155030001","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155030001?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:22","pubTimestamp":1787124132,"startTime":"0","endTime":"0","summary":"BofA Securities has issued a research report indicating that SKB BIO (06990) recorded a 2.9% year-on-year increase in first-half revenue, with pharmaceutical sales revenue more than doubling during...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","161027","BK1161","EWH","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174938251","title":"Movement Alert｜SKB BIO Declines 3.04% in Regular Trading, Profit-Taking as Earnings Quality Questioned Over One-Time Items","url":"https://stock-news.laohu8.com/highlight/detail?id=1174938251","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174938251?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:25","pubTimestamp":1787109901,"startTime":"0","endTime":"0","summary":"On August 19, SKB BIO declined 3.04% in regular trading, trading at HK$525.5/share, with turnover of HK$88.28 million. The stock pulled back after gaining approximately 4% in the prior session on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SKB BIO Declines as Profit-Taking as Earnings Quality Questioned Over One-Time Items","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660498209","title":"China's GenScript Biotech H1 Revenue Rises on AI Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2660498209","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660498209?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:13","pubTimestamp":1787062432,"startTime":"0","endTime":"0","summary":"China's GenScript Biotech H1 revenue rises on AI drug discoveryOverviewChina biotech service provider's H1 2026 revenue rose 27.3% yr/yr, driven by AI drug discoveryAdjusted net profit for H1 2026 sur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F0FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1161","LU2148510915.USD","HK0000306701.USD","SVA","BK1576","BK1583","LU1934453819.USD","BK1230","HK0000165453.HKD","02696","BK0060","BK0239","01548","HK0000306685.HKD","LU1064130708.USD","LU0196878994.USD","00656","002422","06990","HK0000320264.USD","LU1979443071.USD","BK4139","LU1064131003.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660257461","title":"Germany's Immatics Q2 Revenue Rises but Misses Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660257461","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660257461?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:11","pubTimestamp":1787051483,"startTime":"0","endTime":"0","summary":"Germany's Immatics Q2 revenue rises but misses estimatesOverviewGermany cancer cell therapy firm's Q2 collaboration revenue rose but missed analyst expectationsQ2 net loss narrowed year-over-year but ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F0A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002422","LU1064131003.USD","LU1934453819.USD","BK0060","LU1979443071.USD","BK1161","LU1064130708.USD","LU2148510915.USD","BK4139","CVM","BK0239","IMTX","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464776","title":"Sichuan Kelun-Biotech (SEHK:6990) Stock Rebound Meets Profit Quality Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464776","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464776?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:31","pubTimestamp":1787049091,"startTime":"0","endTime":"0","summary":"Investors pushed Sichuan Kelun-Biotech Biopharmaceutical up to HK$542.5 by Monday’s close, after a strong run over the past quarter, yet the fresh numbers tell a more complicated story than the price chart alone. The emotional hook is clear: H1 2026 swung back to profit with basic earnings per share of CN¥1.66 and net income of CN¥388.01m, a sharp contrast to the losses booked through 2025. The question is whether this return to the black justifies the rich P/B multiple and elevated...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotech-sehk6990-stock-rebound-meets-profit-qu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotech-sehk6990-stock-rebound-meets-profit-qu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK4588","BK4585","LU0196878994.USD","BK4581","XBI","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112996152","title":"UBS Lifts SKB BIO Price Target to HK$678 on Strong First-Half Profit Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1112996152","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112996152?lang=en_us&edition=fundamental","pubTime":"2026-08-18 14:37","pubTimestamp":1787035029,"startTime":"0","endTime":"0","summary":"UBS has released a research report raising its price target for SKB BIO (06990) to HK$678, following first-half results that significantly exceeded expectations.The company reported first-half...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","EWH","BK1161","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454593","title":"Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454593","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454593?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:26","pubTimestamp":1787030795,"startTime":"0","endTime":"0","summary":"Switzerland's Basilea H1 revenue rises on Cresemba demand; ups 2026 profit outlookOverviewSwitzerland biopharma firm's H1 2026 revenue grew 14% yr/yr to CHF 119 mlnOperating profit for H1 2026 rose 32","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK7511","HK0000165453.HKD","002422","LU1064131003.USD","BK1161","BK0060","BK7067","HK0000306701.USD","LU2148510915.USD","BK7501","BK1230","06990","LU1064130708.USD","HK0000320223.HKD","02696","LU1934453819.USD","CSL.AU","00656","BK7508","LU1979443071.USD","LU0196878994.USD","HK0000306685.HKD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150971711","title":"Hong Kong Stock Flash | Kelun-Biotech (06990) Surges Over 4% Pre-Noon as Commercial Product Portfolio Scales Up, H1 Product Sales Double Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1150971711","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150971711?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:00","pubTimestamp":1787025621,"startTime":"0","endTime":"0","summary":"Shares of Kelun-Biotech (06990) climbed more than 4% before the midday break, last trading 3.64% higher at HK$541.50 with turnover reaching HK$157 million.According to the company's interim results,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","LU0196878994.USD","BK1161","BK4585","06990","KCAI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159970324","title":"Movement Alert｜SKB BIO Rises 3.25% in Regular Trading, H1 Swing to Profit with Net Income Reaching 388 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1159970324","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159970324?lang=en_us&edition=fundamental","pubTime":"2026-08-18 11:41","pubTimestamp":1787024511,"startTime":"0","endTime":"0","summary":"On August 18, SKB BIO rose 3.25% in regular trading, trading at 540.0 HKD/share, with turnover of HKD 143 million. The move was driven by the company's interim results released on August 17, which...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SKB BIO Rises as H1 Swing to Profit with Net Income Reaching 388 Million Yuan","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197788123","title":"Humanoid Robot Output Ramps Up as Oil and Gas 15th Five-Year Plan Takes Shape","url":"https://stock-news.laohu8.com/highlight/detail?id=1197788123","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197788123?lang=en_us&edition=fundamental","pubTime":"2026-08-18 07:44","pubTimestamp":1787010282,"startTime":"0","endTime":"0","summary":"Humanoid Robot Mass Production Accelerates Significantly; Unitree IPO Set to Reshape Valuation of Core ManufacturersOn August 12, Unitree Technology (688836.SH) announced that its bionic bipedal...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOIL","ERX","DUG","02637","00179","DBC","PXJ","UGAZ","BK1161","ROBO","USL","SG9999002950.SGD","QGmain","DIG","BK4588","XLE","OILU","OIH","NGmain","GUSH","02285","VXUS","06613","KCAI","OILT","LU0196878994.USD","159019","XES","IXC","BK1183","FTXN","06990","FCG","BK1144","PXE","VDE","02432","USOI","WTIU","LU0227179875.USD","PBOT","DRLL","BK1214","BK4570","DGAZ","MNGmain","XOP","BK1170","BK4585","BK1191","DBE","DRIP","IEO","KOLD","UNG","USE","OILK","BNO","KOMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660048753","title":"Vaccine Maker Sinovac H1 Revenue Rises on Overseas Growth, Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048753","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660048753?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:12","pubTimestamp":1786968734,"startTime":"0","endTime":"0","summary":"Vaccine maker Sinovac H1 revenue rises on overseas growth, approvalsOverviewChina vaccine maker's unaudited H1 revenue rose 13% yr/yr, led by overseas sales growthNet loss attributable to common share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL1N44E0BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","BK0239","HK0000320223.HKD","002422","LU1064131003.USD","SVA","LU0196878994.USD","BK1230","HK0000165453.HKD","LU2148510915.USD","BK4139","06990","HK0000306685.HKD","00656","BK1161","BK0060","LU1934453819.USD","HK0000320264.USD","LU1979443071.USD","LU1064130708.USD","02696"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":-0.0528},{"period":"1month","weight":0.034},{"period":"3month","weight":0.2635},{"period":"6month","weight":0.2765},{"period":"1year","weight":-0.0112},{"period":"ytd","weight":0.257}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of drugs. The Company is mainly engaged in the research and development, manufacturing and commercialization of novel drugs in oncology, immunology and other therapeutic areas. The Company's products are antibody drug conjugates (ADCs) SKB264, A166 and others. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancer and other diseases.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.05939},{"month":2,"riseRate":0.666667,"avgChangeRate":0.239909},{"month":3,"riseRate":1,"avgChangeRate":0.292496},{"month":4,"riseRate":1,"avgChangeRate":0.083557},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.011152},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.022649},{"month":7,"riseRate":0.666667,"avgChangeRate":0.111158},{"month":8,"riseRate":1,"avgChangeRate":0.042518},{"month":9,"riseRate":0.75,"avgChangeRate":0.061465},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.03489},{"month":11,"riseRate":1,"avgChangeRate":0.072292},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"SKB BIO","nameEN":"SKB BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SKB BIO(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SKB BIO(06990) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SKB BIO,06990,SKB BIO股票,SKB BIO股票老虎,SKB BIO股票老虎国际,SKB BIO行情,SKB BIO股票行情,SKB BIO股价,SKB BIO股市,SKB BIO股票价格,SKB BIO股票交易,SKB BIO股票购买,SKB BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SKB BIO(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SKB BIO(06990) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}